Greening the Health Sector - Pharmaceuticals and Climate Change

Greening the Health Sector

Dr. Christoph HamelmannRegional Practice Leader HIV, Health and Development

UNDP Europe and Central Asia

CIS Pharmaceutical ForumMoscow, Russia, 5 January 2013

Pharmaceuticals and Climate Changec

c c

Likely Temperature Increaseby GHG Emission Pathways

Energy Intensity (Energy consumption per unit GDP 2011, ENERDATA)

Countries Energy Intensity World Major Country Ranking (highest 4)

Uzbekistan 0.633 1Ukraine 0.436 2Kazakhstan 0.399 3Russia 0.346 4

Countries Unconditional Pledge Conditional Pledge Current GHG Emissions (MtCO2e 2010)

Armenia - Submitted policy actions 11

Azerbaijan - - 50

Belarus Reduction 8 % below 1990 level by 2020 - 150

Kazakhstan Reduction 15 % below 1990 level by 2020 - 318

Kyrgyzstan - - ?

Moldova Reduction 25 % below 1990 level by 2020 - 11

Russia Reduction 15 % below 1990 level by 2020 Reduction 25 % below 1990 level by 2020

2510

Tajikistan - Submitted policy actions 15

Uzbekistan - - 174

Turkmenistan - - 87

Ukraine Reduction 20 % below 1990 level by 2020 - 397

GHG Emission Reduction PledgesCIS Countries

Health Sector in the ECIS Region

• Accounts for 7.5 % of GDP• Technology intensive with significant

consumption of resources, associated with environmental pollution and degradation

• Accounts for an estimated 4.2 % of greenhouse gases (GHG) in the ECIS region

• Up to 25 % of these GHG can be reduced within short-term, more through long-term measures

• Reductions have also direct positive impact on life-years saved

Ministerial European Environment and Health Task Force Meeting, Bled / Slovenia 2011

NHS Carbon Footprint Breakdown 2010

+ others

European Ministerial Environment & Health Task Force

Fifth Ministerial Conferenceon Environment and Health

Parma 2010

53 member states, including all CIS countries

Sector Guidance on Carbon Foot-Printing• Cross-sectoral partnership• Standardized quantification of

the GHG inventory of pharmaceutical products certified by international GHG protocol

• Identification of hot spots throughout the product life cycle

• Focus on minimizing carbon footprint for producers, buyers and users of pharmaceutical products http://www.sdu.nhs.uk/pharma-md

Marginal Abatement Costs

Gaining Efficiencies – Reducing GHG EmissionsLessons Learnt From Pharma-Industry

Stay competitive!

ESA

Economic Commission for EuropeReport Regional Preparatory Meeting

Public procurement47. Sustainable public procurement was supported as a first critical step to further the green economy at the national as well as the sub-national level. Concrete progress was proposed in the form of sustainable public procurement targets that could be met by an increasing number of countries over the years.

Leadership and Innovations

Thank You!

christoph.hamelmann@undp.orgTwitter: @cahamelmann